
Bill Hinshaw
President & Chief Executive Officer
We are a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator (EMM) compositions. EMMs fundamentally impact and regulate metabolism, controlling many of the biological functions that are integral to health and disease. At Axcella, we are seeking to unlock the full potential of EMMs by combining a deep understanding of biological pathways with recent advances in systems biology and machine learning. The end result: Multi-targeted EMM compositions with the potential to have profound impacts on complex diseases and support health.
President & Chief Executive Officer
President, Research and Development
Senior Vice President, Chief Legal Officer and Corporate Secretary
Senior Vice President and Chief Financial Officer
Executive Partner, Flagship Pioneering
Founder, CMR Pharma Consulting
Chief Executive Officer, Nestlé Health Science
Adjunct Professor, University of California San Francisco
Chief Financial Officer, Bluebird Bio
President, Moderna
President & Chief Executive Officer
Chief Medical Officer, Dicerna Pharmaceuticals, Inc.
Harry E. Figgie Professor of Business Administration, Harvard Business School
Whether you are a potential employee, business partner or investor, we want to hear from you.
Distinguished Service Professor & Higginson Professor of Physiology and Medicine, Harvard Medical School
Director, Sarah W. Stedman Nutrition and Metabolism Center Director, Duke Molecular Physiology Institute
Chief Medical Officer, Flagship Pioneering
Chief Executive Officer, Kallyope
Cleveland Family Professor of Pediatric Research Professor of Human Genetics University of Pittsburgh